144 related articles for article (PubMed ID: 29854584)
1. Hyperosmolal vaginal lubricants markedly reduce epithelial barrier properties in a three-dimensional vaginal epithelium model.
Ayehunie S; Wang YY; Landry T; Bogojevic S; Cone RA
Toxicol Rep; 2018; 5():134-140. PubMed ID: 29854584
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Over-The-Counter Lactic Acid Containing Vaginal Gels on the Integrity and Inflammatory State of the Vaginal Epithelium
Tyssen D; Hearps AC; Guntur K; Masson L; Cook S; Moulton SE; Ravel J; Bradshaw CS; Ayehunie S; Tachedjian G
Front Reprod Health; 2022; 4():915948. PubMed ID: 36303665
[TBL] [Abstract][Full Text] [Related]
3. Personal and Clinical Vaginal Lubricants: Impact on Local Vaginal Microenvironment and Implications for Epithelial Cell Host Response and Barrier Function.
Wilkinson EM; Łaniewski P; Herbst-Kralovetz MM; Brotman RM
J Infect Dis; 2019 Nov; 220(12):2009-2018. PubMed ID: 31539059
[TBL] [Abstract][Full Text] [Related]
4. Identification of personal lubricants that can cause rectal epithelial cell damage and enhance HIV type 1 replication in vitro.
Begay O; Jean-Pierre N; Abraham CJ; Chudolij A; Seidor S; Rodriguez A; Ford BE; Henderson M; Katz D; Zydowsky T; Robbiani M; Fernández-Romero JA
AIDS Res Hum Retroviruses; 2011 Sep; 27(9):1019-24. PubMed ID: 21309617
[TBL] [Abstract][Full Text] [Related]
5. Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity.
Dezzutti CS; Brown ER; Moncla B; Russo J; Cost M; Wang L; Uranker K; Kunjara Na Ayudhya RP; Pryke K; Pickett J; Leblanc MA; Rohan LC
PLoS One; 2012; 7(11):e48328. PubMed ID: 23144863
[TBL] [Abstract][Full Text] [Related]
6. Sexual lubricants in South Africa may potentially disrupt mucosal surfaces and increase HIV transmission risk among men who have sex with men.
Rebe KB; De Swardt G; Berman PA; Struthers H; McIntyre JA
S Afr Med J; 2013 Oct; 104(1):49-51. PubMed ID: 24388089
[TBL] [Abstract][Full Text] [Related]
7. Observational cohort study of the effect of a single lubricant exposure during transvaginal ultrasound on cell-shedding from the vaginal epithelium.
O'Hanlon DE; Brown SE; He X; Stennett CA; Robbins SJ; Johnston ED; Wnorowski AM; Mark K; Ravel J; Cone RA; Brotman RM
PLoS One; 2021; 16(5):e0250153. PubMed ID: 33939727
[TBL] [Abstract][Full Text] [Related]
8. Qualification of a non-animal vaginal irritation method admitted as nonclinical assessment model (NAM) in the Incubator Phase of the United States Food and Drug Administration (US FDA) Medical Devices Development Tool (MDDT).
Costin GE; Hill E; Brown J; Clippinger AJ
Toxicol In Vitro; 2020 Feb; 62():104680. PubMed ID: 31626901
[TBL] [Abstract][Full Text] [Related]
9. Mucosal irritation potential of personal lubricants relates to product osmolality as detected by the slug mucosal irritation assay.
Adriaens E; Remon JP
Sex Transm Dis; 2008 May; 35(5):512-6. PubMed ID: 18356773
[TBL] [Abstract][Full Text] [Related]
10. Rectal application of a highly osmolar personal lubricant in a macaque model induces acute cytotoxicity but does not increase risk of SHIV infection.
Vishwanathan SA; Morris MR; Wolitski RJ; Luo W; Rose CE; Blau DM; Tsegaye T; Zaki SR; Garber DA; Jenkins LT; Henning TC; Patton DL; Hendry RM; McNicholl JM; Kersh EN
PLoS One; 2015; 10(4):e0120021. PubMed ID: 25853710
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Commonly Used Excipients on the Epithelial Integrity of Human Cervicovaginal Tissue.
Hu M; Zhou T; Dezzutti CS; Rohan LC
AIDS Res Hum Retroviruses; 2016; 32(10-11):992-1004. PubMed ID: 27611224
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo 2D and 3D HSV-2 infection model using human normal vaginal epithelial cells.
Zhu Y; Yang Y; Guo J; Dai Y; Ye L; Qiu J; Zeng Z; Wu X; Xing Y; Long X; Wu X; Ye L; Wang S; Li H
Oncotarget; 2017 Feb; 8(9):15267-15282. PubMed ID: 28146426
[TBL] [Abstract][Full Text] [Related]
13. Characterization of commercially available vaginal lubricants: a safety perspective.
Cunha AR; Machado RM; Palmeira-de-Oliveira A; Martinez-de-Oliveira J; das Neves J; Palmeira-de-Oliveira R
Pharmaceutics; 2014 Sep; 6(3):530-42. PubMed ID: 25247884
[TBL] [Abstract][Full Text] [Related]
14. Effect of vaginal lubricants on sperm motility and chromatin integrity: a prospective comparative study.
Agarwal A; Deepinder F; Cocuzza M; Short RA; Evenson DP
Fertil Steril; 2008 Feb; 89(2):375-9. PubMed ID: 17509584
[TBL] [Abstract][Full Text] [Related]
15. Effects of Vaginal Lubricants on In-Vitro Progressive Spermatozoa Motility.
Wilson SL; Adam JK; Krishna SBN
Afr J Reprod Health; 2017 Sep; 21(3):96-101. PubMed ID: 29624933
[TBL] [Abstract][Full Text] [Related]
16. Assessment of ospemifene or lubricants on clinical signs of VVA.
Constantine G; Graham S; Koltun WD; Kingsberg SA
J Sex Med; 2014 Apr; 11(4):1033-1041. PubMed ID: 24443923
[TBL] [Abstract][Full Text] [Related]
17. Women's perceptions about lubricant use and vaginal wetness during sexual activities.
Jozkowski KN; Herbenick D; Schick V; Reece M; Sanders SA; Fortenberry JD
J Sex Med; 2013 Feb; 10(2):484-92. PubMed ID: 23211029
[TBL] [Abstract][Full Text] [Related]
18. Effect of vaginal lubricants on natural fertility.
Mesen TB; Steiner AZ
Curr Opin Obstet Gynecol; 2014 Jun; 26(3):186-92. PubMed ID: 24717914
[TBL] [Abstract][Full Text] [Related]
19. Preventing sexual transmission of HIV: anti-HIV bioregulatory and homeostatic components of commercial sexual lubricants.
Nguyen D; Lee H; Poast J; Cloyd MW; Baron S
J Biol Regul Homeost Agents; 2004; 18(3-4):268-74. PubMed ID: 15786693
[TBL] [Abstract][Full Text] [Related]
20. Surfactant Protein D Reverses the Gene Signature of Transepithelial HIV-1 Passage and Restricts the Viral Transfer Across the Vaginal Barrier.
Pandit H; Kale K; Yamamoto H; Thakur G; Rokade S; Chakraborty P; Vasudevan M; Kishore U; Madan T; Fichorova RN
Front Immunol; 2019; 10():264. PubMed ID: 30984160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
